Is CL a good stock to buy? We came across a bullish thesis on Colgate-Palmolive Company on Compounding Dividends’s Substack. In this article, we will summarize the bulls’ thesis on CL. Colgate-Palmolive Company’s share was trading at $92.07 as of June 26th. CL’s trailing and forward P/E were 35.69 and 23.87 respectively according to Yahoo Finance.
Colgate-Palmolive Company is a global leader in household and personal care products with operations spanning more than 200 countries and a portfolio of essential consumer products that generate recurring demand. While widely recognized for its dominant Colgate toothpaste franchise, the company also operates strong personal care, home care, and pet nutrition businesses, creating a diversified revenue base led by oral, personal, and home care, which contribute 77% of sales, while Hill’s Pet Nutrition accounts for the remaining 23%.
Read More: 15 AI Stocks That Are Quietly Making Investors Rich
Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential
Colgate’s competitive advantage stems from its powerful global brands, pricing power, and unmatched distribution network that reaches both developed and emerging markets, allowing it to maintain over 40% share of the global toothpaste market. Management, led by CEO Noel Wallace, has built on these strengths through its 2030 strategic plan, expanding premium offerings and integrating digital and physical retail while delivering six consecutive years of organic sales growth and annual revenue exceeding $20 billion.
The business also stands out for disciplined capital allocation, consistently generating high returns on invested capital and returning capital to shareholders through more than $1 billion in annual share repurchases. As a Dividend King with 63 consecutive years of dividend increases, Colgate offers exceptional income stability despite a modest recent dividend growth rate.
Long-term growth is underpinned by improving hygiene awareness across emerging markets and continued strength in the higher-growth pet nutrition segment, which is benefiting from rising pet humanization trends and is expected to outpace the expansion of traditional consumer staples.
While competitive pressures, foreign exchange volatility, input cost inflation, and the maturity of core categories continue to pose structural risks, Colgate’s strong cash flow generation, conservative balance sheet, healthy interest coverage, and well-established brand portfolio support its positioning as a high-quality dividend growth company with the ability to compound shareholder returns steadily over the long term.
Previously, we covered a bullish thesis on Colgate-Palmolive Company (CL) by Kontra in October 2024, which highlighted the company’s quality compounder characteristics, supported by premium brands, pricing power, and high ROIC. CL’s stock price has depreciated by approximately 8.35% since our coverage. Compounding Dividends shares a similar view but emphasizes on dividend growth, resilient cash generation, and long-term growth through pet nutrition.
Colgate-Palmolive Company is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 62 hedge fund portfolios held CL at the end of the first quarter which was 62 in the previous quarter. While we acknowledge the risk and potential of CL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than CL and that has 10,000% upside potential, check out our report about this cheapest AI stock.
Disclosure: None.
